Analysis of Tubespins as a suitable scale‐down model of bioreactors for high cell density CHO cell culture
暂无分享,去创建一个
Li Zhang | Jonathan Lull | Natalia Gomez | J. Lull | Chung-Jr Huang | Malhar Ambhaikar | Hedieh Barkhordarian | Chris Gutierrez | Natalia Gomez | M. Ambhaikar | Hedieh Barkhordarian | Li Zhang | Chung‐Jr Huang | C. Gutierrez
[1] A. Quarteroni,et al. Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale. , 2009, Advances in biochemical engineering/biotechnology.
[2] Suzanne S Farid,et al. Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty , 2013, Biotechnology and bioengineering.
[3] Lisa Connell-Crowley,et al. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development , 2015, mAbs.
[4] Difei Qiu,et al. C‐terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes , 2008, Biotechnology and bioengineering.
[5] Philippe Girard,et al. TubeSpin satellites: a fast track approach for process development with animal cells using shaking technology , 2004 .
[6] W. Hsu,et al. Advanced microscale bioreactor system: a representative scale-down model for bench-top bioreactors , 2012, Cytotechnology.
[7] A. Sreedhara,et al. Effect of ambient light on monoclonal antibody product quality during small‐scale mammalian cell culture process in clear glass bioreactors , 2014, Biotechnology progress.
[8] S. Gupta,et al. Effects of Elevated pCO2 and Osmolality on Growth of CHO Cells and Production of Antibody‐Fusion Protein B1: A Case Study , 2008, Biotechnology progress.
[9] D. Lütkemeyer,et al. Mapping and partial characterization of proteases expressed by a CHO production cell line , 2006, Biotechnology and bioengineering.
[10] Konstantin B Konstantinov,et al. The future of industrial bioprocessing: batch or continuous? , 2015, Biotechnology and bioengineering.
[11] Weichang Zhou,et al. Development and application of a high-throughput platform for perfusion-based cell culture processes. , 2015, Journal of biotechnology.
[12] K. Xie,et al. On-line monitoring of oxygen in Tubespin, a novel, small-scale disposable bioreactor , 2011, Cytotechnology.
[13] Christopher Miller,et al. High‐throughput miniaturized bioreactors for cell culture process development: Reproducibility, scalability, and control , 2014, Biotechnology progress.
[14] P. V. van Berkel,et al. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.
[15] D K Robinson,et al. Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process , 1994, Biotechnology and bioengineering.
[16] Marcella Yu,et al. Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform , 2011, Biotechnology and bioengineering.
[17] Jun Luo,et al. Probing of C‐terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media , 2012, Biotechnology and bioengineering.
[18] W. Miller,et al. Production of tPA in recombinant CHO cells under oxygen‐limited conditions , 1993, Biotechnology and bioengineering.
[19] Chung-Jr Huang,et al. A robust method for increasing Fc glycan high mannose level of recombinant antibodies , 2015, Biotechnology and bioengineering.